The Jeonnam Bio Center has trained 15 new professionals in the production and quality control of biopharmaceuticals.
The center's Biopharmaceutical Division held a graduation ceremony on September 30 for the '2026 Biopharmaceutical GMP (Good Manufacturing Practice) Practical Course,' marking the completion of an 8-week hands-on training program.
This course is part of a professional training program supported by the Ministry of Trade, Industry and Energy and the Korea Industrial Technology Promotion Agency. It focuses on developing practical personnel needed in the biopharmaceutical industry across regional centers nationwide.
Trainees completed courses essential for biopharmaceutical production, including vaccine GMP manufacturing hygiene, microbial and animal cell culture and purification, vaccine quality control testing, GMP utilities, and document management.
The program emphasized not only theoretical education but also practical experiments and employment readiness programs to enhance adaptability in the industry after graduation.
The Biopharmaceutical Division has been training professionals for over a decade. According to the division, since starting its support project in 2014, it has produced a total of 295 graduates.
Employment outcomes have also been promising. The Biopharmaceutical Division reported that the average employment rate for graduates has exceeded 80%. This year's recruitment materials for the national biopharmaceutical training program indicated an employment rate of around 80% for the previous year.
Investments have also been made to expand training facilities. The Biopharmaceutical Division has invested a total of 6 billion won to establish GMP training rooms and Non-GMP experimental and practical facilities, utilizing these facilities to conduct various tailored training programs for approximately 600 individuals to date.
Official documents from the Jeonnam Bio Center highlight the training of professionals in the entire lifecycle of domestic and international biopharmaceutical GMP as one of the division's key projects.
Seo Dong-sam, head of the Biopharmaceutical Division, stated, “I hope the graduates will grow into key talents who will lead the biopharmaceutical industry based on their practical skills. We will continue to expand tailored training that meets industry needs, and we plan to launch global training for overseas biopharmaceutical professionals by the end of this year.”
Meanwhile, the Biopharmaceutical Division is broadening its training targets to include not only job seekers but also university students and industry professionals, utilizing its practical infrastructure in GMP production and quality control. Plans are underway to expand training programs for overseas biopharmaceutical professionals alongside domestic professional training.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.